AXA SA AI Stock Analysis
Want to see FR:CS full AI Analyst Report?
AXA SA (CS) AI Stock Analysis
AXA SA
(Paris:CS)
The score is driven primarily by solid financial performance (strong cash generation and improving profitability, though with a notable 2025 operating-profit data inconsistency) and attractive valuation (low P/E and high dividend yield). Technicals are supportive with an uptrend and positive momentum, but near-overbought stochastic readings slightly limit upside in the near term.
AXA SA (CS) vs. iShares MSCI France ETF (EWQ)
- Market Cap
- EUR 96.96B
- Dividend Yield
- 4.93%
- Average Volume (3M)
- 3.08M
- Price to Earnings (P/E)
- 9.6
- Beta (1Y)
- 0.98
- Revenue Growth
- 10.86%
- EPS Growth
- 36.10%
- Country
- France
- Employees
- 107,756
- Sector
- General
- Sector Strength
- 55
- Industry
- Insurance - Diversified
AXA SA Business Overview & Revenue Model
Company Description
AXA S.A. operates as a global financial services group, delivering a comprehensive suite of insurance, asset management, and banking services across the globe through its various subsidiaries. The company is structured into key operational segments,...
How the Company Makes Money
AXA primarily makes money through its insurance and asset management activities. In insurance, it earns revenue by collecting premiums from policyholders in its P&C and life & health lines. Profitability depends on underwriting results—pricing risk a...
AXA SA Financial Statement Overview
Summary
Overall fundamentals are solid, led by strong cash generation (Cash Flow Score 81) and improving profitability with net income rising from 2022–2025 (6.7B to 9.8B). Balance sheet improved in 2025 with materially lower leverage and higher ROE, but the Balance Sheet Score (62) reflects historical inconsistency in capital structure. A key risk is the 2025 operating-profit data inconsistency (EBIT/EBITDA reported as zero), which reduces confidence in operating trend quality despite strong net income.
Income Statement
74PositiveBalance Sheet
62PositiveCash Flow
81Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 116.79B | 109.23B | 107.87B | 100.18B | 86.09B | 110.65B |
| Gross Profit | 37.55B | 31.38B | 34.09B | 28.50B | 11.62B | 32.87B |
| EBITDA | 10.43B | 9.89B | 10.02B | 8.48B | 7.29B | 10.53B |
| Net Income | 10.05B | 9.80B | 7.89B | 7.19B | 5.06B | 7.29B |
Balance Sheet | ||||||
| Total Assets | 650.69B | 635.50B | 653.80B | 644.45B | 696.70B | 775.49B |
| Cash, Cash Equivalents and Short-Term Investments | 18.52B | 22.20B | 333.57B | 320.12B | 323.68B | 25.05B |
| Total Debt | 64.88B | 61.88B | 62.14B | 59.54B | 63.75B | 57.22B |
| Total Liabilities | 607.47B | 586.00B | 606.12B | 592.05B | 648.32B | 692.51B |
| Stockholders Equity | 40.92B | 42.56B | 49.90B | 44.14B | 45.35B | 71.14B |
Cash Flow | ||||||
| Free Cash Flow | 13.50B | 21.05B | 11.09B | 5.16B | 7.53B | 6.18B |
| Operating Cash Flow | 13.92B | 21.48B | 11.57B | 5.59B | 7.88B | 6.53B |
| Investing Cash Flow | -8.88B | -10.63B | -11.25B | -1.60B | 470.00M | -8.95B |
| Financing Cash Flow | -10.90B | -8.13B | -7.33B | -5.93B | -6.12B | -4.33B |
AXA SA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:CS, the sentiment is Positive. The current price of 46.77 is above the 20-day moving average (MA) of 43.89, above the 50-day MA of 43.44, and above the 200-day MA of 41.25, indicating a bullish trend. The MACD of 0.98 indicates Negative momentum. The RSI at 72.13 is Negative, neither overbought nor oversold. The STOCH value of 94.64 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:CS.
AXA SA Peers Comparison
Overall Rating
FR:CS78Outperform
FR:AMUN68Neutral
FR:COFA67Neutral
FR:BNP62Neutral
FR:CAF58Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 78Outperform | EUR 96.96B | 9.57 | 24.07% | 4.93% | 10.86% | 36.10% | |
| 68Neutral | EUR 19.37B | 11.67 | 13.13% | 4.40% | 1.21% | -18.98% | |
| 67Neutral | EUR 2.41B | 12.06 | 9.18% | 7.74% | 1.48% | -12.43% | |
| 62Neutral | EUR 105.57B | 9.96 | 8.80% | 6.07% | 7.57% | 22.65% | |
| 58Neutral | EUR 763.30M | 10.27 | 2.86% | 2.70% | -4.60% | 22.52% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FR:CS | AXA SA (UK) | 46.77 | 11.05 | 30.94% | |
| FR:AMUN | Amundi SA | 95.85 | 34.86 | 57.15% | |
| FR:BNP | BNP Paribas SA (UK) | 95.44 | 32.76 | 52.26% | |
| FR:CAT31 | Caisse Regionale de Credit Agricole Mutuel Toulouse 31 | 99.01 | -8.76 | -8.13% | |
| FR:CAF | CRCAM dlle-de France | 96.30 | -3.78 | -3.78% | |
| FR:COFA | Coface SA | 16.10 | 2.46 | 18.02% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
